MIST
Milestone Pharmaceuticals Inc
0.7572$
-0.9%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | 100.0% | – | 100.0% | 100.0% | 100.0% | – | – | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | 100.0% | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | 0.2% | – | 62.8% | 64.9% | 1.9% | – | – | 655.1% | 11.6% | 1.8% | – | – | – | – | – | – | 525.0% | – | – | – | 2.2% | 29.4% | 5.7% | 6.9% | |
| – | – | – | – | – | – | – | – | – | – | – | -0.2% | – | 100.0% | -64.9% | -1.9% | – | – | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | -525.0% | – | – | – | 100.0% | 70.6% | 94.3% | 94.6% | |
| – | – | – | – | – | – | – | – | – | – | – | 10.0% | – | 63.4% | 66.2% | 72.7% | – | – | 655.1% | 306.1% | 1,025.7% | – | – | – | – | – | – | 3,648.1% | – | – | – | 357.1% | 1,411.8% | 627.7% | 700.1% | |
| – | – | – | – | – | – | – | – | – | – | – | 2.9% | – | 20.1% | 19.7% | 25.2% | – | – | 268.9% | 103.8% | 388.9% | – | – | – | – | – | – | 3,704.6% | – | – | – | 328.9% | 2,026.9% | 4,051.5% | 1,527.7% | |
| – | – | – | – | – | – | – | – | – | – | – | 15.1% | – | 95.3% | 30.3% | 111.4% | – | – | 1,102.0% | 493.1% | 1,650.2% | – | – | – | – | – | – | 11,433.3% | – | – | – | 1,216.2% | 10,058.8% | 4,679.2% | 3,447.6% | |
| – | – | – | – | – | – | – | – | – | – | – | -15.3% | – | 4.7% | -95.2% | -113.3% | – | – | -1,002.0% | -393.1% | -1,550.2% | – | – | – | – | – | – | -11,433.3% | – | – | – | -1,116.2% | -9,988.2% | -4,585.0% | -3,353.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | 0.4% | – | 0.2% | – | – | 31.6% | 898.1% | 3.3% | – | – | – | – | – | – | 850.9% | – | – | – | 63.7% | 1,737.4% | 845.3% | 461.5% | |
| – | – | – | – | – | – | – | – | – | – | – | -15.1% | – | 5.1% | -94.8% | -113.1% | – | – | -970.4% | -376.5% | -1,495.0% | – | – | – | – | – | – | -11,447.2% | – | – | – | -1,126.1% | -10,997.9% | -5,118.8% | -3,593.4% | |
| – | – | – | – | – | – | – | – | – | – | – | 0.0% | – | -0.6% | -1.3% | -0.5% | – | – | -31.6% | -898.1% | -55.2% | – | – | – | – | – | – | -60.2% | – | – | – | -6.1% | -45.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -15.1% | – | 5.1% | -94.8% | -112.6% | – | – | -970.4% | -376.5% | -1,495.0% | – | – | – | – | – | – | -11,447.2% | – | – | – | -1,126.1% | -10,952.1% | -5,118.8% | -3,585.6% | |
| – | – | – | – | – | – | – | – | – | – | – | -14.9% | – | 5.3% | -94.7% | -111.1% | – | – | -968.6% | -376.1% | -1,489.9% | – | – | – | – | – | – | -10,572.2% | – | – | – | -1,060.2% | -9,237.0% | -4,263.3% | -3,124.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.